<html><head></head><body><h1>Kerol AD</h1><p class="drug-subtitle"><b>Generic Name:</b> urea emulsion<br/>
<b>Dosage Form:</b> emulsion<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Side Effects</li>
<li>Dosage</li>
<li><b class="nav-item here">Professional</b></li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.</p><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Warnings</li>
<li>Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><p class="First"><span class="Bold">For external use only. Not for ophthalmic use.</span></p><p>Rx only</p><p>The Kerol AD brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.</p><h2>DESCRIPTION</h2><p class="First">Each mL of <span class="Bold">Kerol</span><span class="Sup">TM</span> <span class="Bold">AD</span> contains 45% urea in a formulation consisting of: propylene glycol, caprylic/capric triglycerides, polyethylene glycol 300, purified water, trolamine, vitamin E acetate, lactic acid, glycerin, polysorbate-60, linoleic acid, sorbitan monostearate, zinc undecylenate, titanium dioxide, cetyl alcohol, EDTA disodium, hydroxyethyl cellulose and xanthan gum.</p><p>Urea is a diamide of carbonic acid with the following chemical structure:</p><h2>CLINICAL PHARMACOLOGY</h2><p class="First">Urea gently dissolves the intercellular matrix, which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas.</p><h2>PHARMACOKINETICS</h2><p class="First">The mechanism of action of topically applied Urea is not yet known.</p><h2>INDICATIONS AND USES</h2><p class="First">For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses.</p><h2>CONTRAINDICATIONS</h2><p class="First">Known hypersensitivity to any of the listed ingredients.</p><h2>WARNINGS</h2><p class="First">For external use only. Avoid contact with eyes, lips or mucous membranes.</p><h2>PRECAUTIONS</h2><p class="First">This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use.</p><h2>PREGNANCY</h2><p class="First">Pregnancy Category B. Animal reproduction studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, <span class="Bold">Kerol</span><span class="Sup">TM</span> <span class="Bold">AD</span> should be given to a pregnant woman only if clearly needed.</p><h2>NURSING MOTHERS</h2><p class="First">It is not known whether or not this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when <span class="Bold">Kerol</span><span class="Sup">TM</span> <span class="Bold">AD</span> is administered to a nursing woman.</p><p><span class="Bold">KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.</span></p><h2>Adverse Reactions</h2><p class="First">Transient stinging, burning, itching or irritation may occur and normally disappear on discontinuing the medication.</p><h2>DOSAGE AND ADMINISTRATION</h2><p class="First">Apply <span class="Bold">Kerol</span><span class="Sup">TM</span> <span class="Bold">AD</span> to affected skin twice per day, or as directed by a physician. Rub in until completely absorbed.</p><h2>HOW SUPPLIED</h2><p class="First"><span class="Bold">Kerol</span><span class="Sup">TM</span> <span class="Bold">AD</span> (45% urea emulsion) is supplied as:</p><p>240 mL bottle, NDC 10337-643-24</p><p>Store at 15˚-30˚ C (59˚- 86˚ F).</p><p>Protect from freezing.</p><p>Mfd. for:<br/>
PharmaDerm<span class="Sup">®</span><br/>
A division of Nycomed US Inc.<br/>
Melville, NY 11747 USA<br/>
www.pharmaderm.com</p><p>Mfd. by:<br/>
Pegasus Laboratories, Inc.<br/>
Pensacola, FL 32514</p><p>IF643<br/>
R5/09</p><p class="First"><span class="Bold">How to use</span></p><p>Rx only<br/>
<span class="Bold">Kerol™ AD<br/></span> (45% urea emulsion)<br/>
<span class="Bold Italics">Accu-Dose<br/></span> In a zinc undecylenate and lactic acid vehicle<br/></p><p>Steps for using Kerol AD to treat dry skin conditions including psoriasis, xerosis, ichthyosis, keratosis pilaris, keratosis palmaris, keratoderma, dermatitis, pruritus, eczema, corns and calluses.</p><p>Kerol AD can be applied directly to the treatment area(s) without pouring from a bottle or squeezing from a tube. The pump is designed to consistently deliver a precise amount of Kerol AD with each use once the pump has been primed and medication is delivered to the spout. To begin using Kerol AD:</p><p><span class="Italics">*</span> <span class="Bold Italics">Sample bottles</span> of Kerol AD have a different fill ratio and will need to be pumped <span class="Bold">eight to ten times</span> to prime the chamber and get the Kerol AD to pass through the spout.</p><p class="First"><span class="Bold">PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 240 mL CONTAINER LABEL</span></p><p><span class="Bold">NDC 10337-643-24</span></p><p>PharmaDerm<span class="Sup">®</span></p><p><span class="Bold">NDC</span> 10337-643-24</p><p>Rx only</p><p>KEROL<span class="Sup">™</span> AD<br/>
(45% urea emulsion)<br/>
Accu-Dose</p><p>In a zinc undecylenate and lactic acid vehicle</p><p><span class="Bold">For Topical Use Only</span></p><p>Net Content 240 mL</p><p class="First"><span class="Bold">PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 240 mL CARTON</span></p><p>PharmaDerm<span class="Sup">®</span></p><p><span class="Bold">NDC</span> 10337-643-24</p><p>Rx only</p><p>KEROL<span class="Sup">™</span> AD<br/>
(45% urea emulsion)<br/>
Accu-Dose</p><p>In a zinc undecylenate and<br/>
lactic acid vehicle</p><p><span class="Bold">For Topical<br/>
Use Only</span></p><p>Net Content 240 mL</p><h2>More about Kerol AD (urea topical)</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>Dosage Information</li>
<li>Drug class: topical emollients</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Dermatological Disorders</li>
<li>Dry Skin</li>
<li>Pityriasis rubra pilaris</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>